Sep 2026· Current Opinion in Psychiatry· 0 citations· 38 references
Medicine
TL;DR
Recent developments have expanded the understanding of the way the genetic basis of autism manifests phenotypically, and illustrate the therapeutic potential of gene-first approaches for selected monogenic neurodevelopmental disorders.
Abstract
Purpose
OF REVIEW
This paper covers some of the key findings on the topic of genetic influences in autism over the last 12-18 months, which consist of significant conceptual shifts and new insights from recent technological advances.
RECENT
Findings
Autism is a highly heritable condition, with significant heterogeneity of the genes that influence the development of this condition. The heterogeneity of autism, and multiple pathways contributing to the development of an autistic phenotype, create challenges in our understanding, diagnosis, and management of this condition.Recent studies of common genetic variation and polygenic risk scores have focussed on resolving phenotypic heterogeneity and identifying meaningful autism subtypes. Rare-variant discovery has expanded across ancestries, the X chromosome, noncoding loci, structural variants, and tandem repeats, aided by long-read and pangenome-informed sequencing. Single-cell multiomics, spatial perturbation methods and human organoid models have connected genetic variation to cell-type-specific and developmental phenotypes, while also revealing substantial mutation-specific effects and methodological sensitivity. Genetic testing increasingly provides aetiological diagnoses and informs medical surveillance. Recent developments also illustrate the therapeutic potential of gene-first approaches for selected monogenic neurodevelopmental disorders.
SUMMARY
Recent developments have expanded our understanding of the way the genetic basis of autism manifests phenotypically.
This study finds that rare variants across hundreds of genes contribute to autism with variable phenotypic outcomes, and clusters them based on association evidence from large-scale studies of developmental disorders, schizophrenia, bipolar disorder, and epilepsy.
F. Satterstrom, C. Auwerx, J.-M. Fu et al.· medRxiv· 1 citation
This study underscores the importance of subtyping in genetic analyses and provides a framework to disentangle confounded genetic pathways and provides a framework to disentangle confounded genetic pathways.
Sophie Breunig, L. Schaffer, Jeremy M. Lawrence et al.· Behavior Genetics· 0 citations
This study provides the first comprehensive genomic overview of ASD in a large Brazilian cohort, reinforcing the critical need to include diversely admixed populations in genomic research to expand the understanding of ASD architecture and improve diagnostic strategies in resource-limited settings.
Gabriele da Silva Campos, C. I. S. Costa, J. Wang et al.· Genetics and Molecular Biolo...· 0 citations
This review synthesizes current understanding of the genetic architecture of Alzheimer’s disease in the era of next-generation sequencing, with particular emphasis on variant classes beyond single nucleotide polymorphisms, and discusses somatic mosaicism that represents another layer of its complexity.
L. Lukyova, A. Zaťková, J. Minarík et al.· 0 citations
The reasons for the slow pace of the diffusion of polygenic risk scores, along with the related field of pharmacogenomics, may be useful in clinical practice for the prevention and treatment of common diseases are reviewed.
David J. Hunter, Michael Inouye· New England Journal of Medic...· 0 citations
It is found that damaging de novo single-nucleotide variants and frameshift indels explain 3.4% (95% CI: 2.1% - 4.7%) of autism variance on the observed scale.
A. Nadig, J. Fu, F. Satterstrom et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.